In the ever-evolving field of diabetes management, GLP-1 receptor agonists have emerged as a transformative therapeutic class. Among these, retaglutide, retatrutide, and trizepatide represent novel additions to the https://miriamzrcz304673.mdkblog.com/45178040/novel-glp-1-receptor-agonists-retaglutide-retatrutide-and-trizepatide